down arrow

Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,402.05
-1 (-0.07%)
BSENSE

Dec 05

BSE+NSE Vol: 43.32 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Granules India
Natco Pharma
Sai Life
Jubilant Pharmo
Alivus Life
Alembic Pharma
Caplin Point Lab
Sanofi Consumer
Concord Biotech
OneSource Speci.
Why is Concord Biotech Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -0.48% of over the last 5 years
2
Negative results in Sep 25
  • PBT LESS OI(Q) At Rs 72.33 cr has Fallen at -32.1% (vs previous 4Q average)
  • OPERATING CF(Y) Lowest at Rs 244.52 Cr
  • PAT(Latest six months) At Rs 107.64 cr has Grown at -30.70%
3
With ROE of 17.7, it has a Very Expensive valuation with a 8 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -35.44%, its profits have fallen by -1.2%
4
Below par performance in long term as well as near term
  • Along with generating -35.44% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Concord Biotech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Concord Biotech
-36.03%
-0.81
43.98%
Sensex
4.84%
0.39
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.68%
EBIT Growth (5y)
-0.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.66
Tax Ratio
24.63%
Dividend Payout Ratio
24.63%
Pledged Shares
0
Institutional Holding
17.59%
ROCE (avg)
29.08%
ROE (avg)
19.17%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
45
Industry P/E
34
Price to Book Value
8.01
EV to EBIT
38.26
EV to EBITDA
32.67
EV to Capital Employed
9.56
EV to Sales
12.72
PEG Ratio
NA
Dividend Yield
0.76%
ROCE (Latest)
24.99%
ROE (Latest)
17.73%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DPS(Y)

Highest at Rs 10.70

-15What is not working for the Company
PBT LESS OI(Q)

At Rs 72.33 cr has Fallen at -32.1% (vs previous 4Q average

OPERATING CF(Y)

Lowest at Rs 244.52 Cr

PAT(Latest six months)

At Rs 107.64 cr has Grown at -30.70%

ROCE(HY)

Lowest at 23.48%

NET SALES(Q)

At Rs 247.06 cr has Fallen at -16.8% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Concord Biotech
Dividend per Share (DPS) - Annually
Highest at Rs 10.70 and Grown
each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)

Here's what is not working for Concord Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 72.33 cr has Fallen at -32.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 106.49 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 63.58 cr has Fallen at -28.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 89.03 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 247.06 cr has Fallen at -16.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 297.07 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Operating Cash Flow - Annually
Lowest at Rs 244.52 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."